Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy.

Leukemia
S MerimsL Zhang

Abstract

CD3(+)CD56(-), CD4 and CD8 double negative T (DNT) cells comprise 1-3% of peripheral blood (PB) mononuclear cells. Their role in tumor immunity remains largely unknown due to their limited numbers and lack of effective methods to expand them. Here we developed a novel protocol by which DNT cells can be expanded ex vivo to therapeutic levels in 2 weeks from 13 of 16 acute myeloid leukemia (AML) patients during chemotherapy-induced complete remission. The expanded DNT cells expressed similar or higher levels of interferon-γ and tumor necrosis factor-α and Granzyme B as that seen in bulk activated CD8T cells from the same patient but significantly higher levels of perforin. The expanded DNT cells could effectively kill both allogeneic and autologous primary CD34(+) leukemic blasts isolated from PB of AML patients in a perforin-dependant manner. These results demonstrate, for the first time, that DNT cells from AML patients can be expanded ex vivo even after intensive chemotherapy, and are effective at killing both allogeneic and autologous primary leukemic blasts. These findings warrant studies further exploring the potential of DNT cells as a novel adjuvant immunotherapy to decrease the risk of relapse in patients with AML and, p...Continue Reading

References

Jul 1, 1991·The Journal of Experimental Medicine·I G Schmidt-WolfI L Weissman
Jul 3, 1991·Journal of the National Cancer Institute·P AebersoldS A Rosenberg
Jul 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D J SchwartzentruberS L Topalian
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R H CollinsJ Nemunaitis
May 15, 2001·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J C AlvarnasR S Negrin
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John E LevineRobert H Collins
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paul A AntonyNicholas P Restifo
Mar 4, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Lawrence S Lamb, Richard D Lopez
Mar 4, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Thomas LeemhuisRobert S Negrin
Dec 2, 2006·Nature Clinical Practice. Oncology·Pawel MuranskiNicholas P Restifo
Jan 11, 2007·Cancer Research·Dieter KabelitzWei He
Jun 6, 2007·The Journal of Clinical Investigation·Carl H June
Mar 21, 2008·Nature Reviews. Cancer·Steven A RosenbergMark E Dudley
Apr 10, 2008·Nature Clinical Practice. Oncology·Taner DemirerUNKNOWN EBMT Solid Tumors Working Party
Jun 21, 2008·The New England Journal of Medicine·Naomi N HunderCassian Yee
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Oct 7, 2009·British Journal of Haematology·Mark R LitzowUNKNOWN Eastern Cooperative Oncology Group Leukemia Committee
Nov 12, 2009·Blood·Lars BullingerDirk van den Boom

❮ Previous
Next ❯

Citations

Mar 14, 2014·Endocrine-related Cancer·Shahnawaz ImamJuan Carlos Jaume
Jul 17, 2012·Cytokine & Growth Factor Reviews·Martin WieczorekOliver H Krämer
Dec 1, 2015·Biochemical and Biophysical Research Communications·Hong XuJiong Chen
May 15, 2012·Bioinformatics·Daniela BeisserTobias Müller
Apr 25, 2018·Journal of Experimental & Clinical Cancer Research : CR·Branson ChenLi Zhang
Dec 28, 2017·Critical Reviews in Food Science and Nutrition·Arshad MehmoodAmjad Abbas Shah
Jul 17, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shikhar MehrotraMichael I Nishimura
Mar 13, 2019·Journal of Experimental & Clinical Cancer Research : CR·Linan FangLi Zhang
Sep 22, 2017·JCI Insight·Simon KavanaghAaron D Schimmer
Oct 28, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·JongBok LeeLi Zhang
Jan 9, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jong Bok LeeLi Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.